ArticleBiomedical engineering and computational biology2024

Reclassify High-Grade Serous Ovarian Cancer Patients Into Different Molecular Subtypes With Discrepancy Prognoses and Therapeutic Responses Based on Cancer-Associated Fibroblast-Enriched Prognostic Genes.

Xiangxiang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.